Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 3. Rapid correction of low vitamin D status in nursing home residents 4. 2008 Exclusive Survey—Earnings: Good news for primary care income 5. Medicare pay-for-reporting effort draws fire from frustrated doctors
Your Article Summary
Long term effect of external pituitary irradiation on IGF1 levels in patients with acromegaly free of adjunctive treatment
European Journal of Endocrinology, 08/07/09
Mullan K et al. – The authors have found that a significant number of patients (25/57) achieved persistently normal IGF–1 free of adjunctive treatment for at least 1 year, after external pituitary irradiation for acromegaly. This demonstrates that, with time, external pituitary irradiation achieves a normal IGF–1 in significant numbers of patients with acromegaly, thus obviating the need for life–long expensive medical therapy. For each patient this benefit has to be weighed against the possibility of new hypopituitarism as a result of the treatment. Any decision to use external pituitary irradiation is easier in the context of pre–existent hypopituitarism.
Related Articles
The Exon 3-Deleted Growth Hormone Receptor Is Associated with Better Response to Pegvisomant Therapy in Acromegaly
Journal of Clinical Endocrinology and Metabolism, 11/12/09
Relevance Score: 88%
The Exon-3 Deleted Growth Hormone Receptor Polymorphism Predisposes to Long-Term Complications of Acromegaly
Journal of Clinical Endocrinology and Metabolism, 11/12/09
Relevance Score: 87%
Discordant Nadir GH After Oral Glucose and IGF-I Levels on Treated Acromegaly: Refining the Biochemical Markers of Mild Disease Activity
Hormone and Metabolic Research, 10/06/09
Relevance Score: 87%
Prevalence of mental disorders in acromegaly: a cross-sectional study in 81 acromegalic patients
Clinical Endocrinology, 10/15/09
Relevance Score: 85%
ACTH Deficiency, Higher Doses of Hydrocortisone Replacement, and Radiotherapy Are Independent Predictors of Mortality in Patients with Acromegaly
Journal of Clinical Endocrinology and Metabolism, 10/14/09
Relevance Score: 85%
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
TCF7L2 Variant rs7903146 Affects the Risk of Type 2 Diabetes by Modulating Incretin Action
Diabetes, 11/25/09
Regulation of MAP-kinase-directed mitogenic and PKB-mediated signalling by cannabinoid receptor type 1 in skeletal muscle cells
Diabetes, 11/25/09
Examination of all type 2 diabetes GWAS loci reveals HHEX-IDE as a locus influencing pediatric BMI
Diabetes, 11/25/09
Today in Neuroendocrinology...keeping you current
Receive free subspecialty "5-minute updates" via email
Familial Cervical Paragangliomas with Lymph Node Metastasis Expressing Somatostatin Receptor Type 2A
Endocrine Pathology, 11/25/09
Davalintide (AC2307), a novel amylin-mimetic peptide: enhanced pharmacological properties over native amylin to reduce food intake and body weight
International Journal of Obesity, 11/25/09
Neuroendocrine carcinomas arising in solid-organ transplant recipients: rare but aggressive malignancies
Oncology (Karger), 11/25/09
Sponsor
Article Search
Sponsor


See Latest Articles


